EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00
Source: finanznachrichten.de